Proteome analysis of diabetic-related proteins in rat kidney by fluorogenic derivatization–liquid chromatography–tandem mass spectrometry (FD-LC-MS/MS) method

碩士 === 臺北醫學大學 === 藥學研究所 === 98 === Diabetic nephropathy (DN) is a complication of diabetes mellitus which may lead to end-stage renal disease. Throughout its early course, DN has no symptoms. The first laboratory abnormality is a positive sign by microalbuminuria test. However, at this stage, a kidn...

Full description

Bibliographic Details
Main Authors: Pei-Yun Tsai, 蔡佩芸
Other Authors: 李仁愛
Format: Others
Language:zh-TW
Published: 2010
Online Access:http://ndltd.ncl.edu.tw/handle/74321667674778863473
id ndltd-TW-098TMC05551020
record_format oai_dc
spelling ndltd-TW-098TMC055510202016-04-22T04:23:30Z http://ndltd.ncl.edu.tw/handle/74321667674778863473 Proteome analysis of diabetic-related proteins in rat kidney by fluorogenic derivatization–liquid chromatography–tandem mass spectrometry (FD-LC-MS/MS) method 大鼠腎臟中糖尿病相關蛋白之蛋白質體之螢光高效能液相層析串聯質譜分析 Pei-Yun Tsai 蔡佩芸 碩士 臺北醫學大學 藥學研究所 98 Diabetic nephropathy (DN) is a complication of diabetes mellitus which may lead to end-stage renal disease. Throughout its early course, DN has no symptoms. The first laboratory abnormality is a positive sign by microalbuminuria test. However, at this stage, a kidney biopsy clearly shows DN. Therefore, this study is designed to establish a new method to identify the differential expression of proteins in the kidney of control and streptozotocin (STZ)-induced diabetic rats in order to discover specific indicators for early diagnosis of DN. The Spregue-Dawley rats were sacrificed at 1, 4, 12, 24 weeks after i.p. injection of sodium citrate buffer or STZ. A thiol-specific fluorogenic reagent, 4-[2-(dimethylamino)ethyl]-7-chloro-2,1,3-benzoxadiazole-4-sulfonamide (DAABD-Cl) was utilized for the derivatization of proteins and then the derivatives were quantified and collected by high performance lipid chromatography with fluorescence detection (FD-HPLC). The isolated derivatives will be further identified by liquid chromatography tandem mass spectrometry (LC-MS/MS) with the MASCOT database searching system. After 1 week of injection, the expressions of approximately 7 proteins significantly changed. Only one protein had significantly changed after 4 weeks of injection. However, after 12 weeks of treatment, the number of altered proteins rose to 9. In addition, the changes appeared before the increase of microalbumin in the urine. The results may serve to find new biomarkers to improve early detection and new drug development in diabetic-related nephropathy. 李仁愛 2010 學位論文 ; thesis 70 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 臺北醫學大學 === 藥學研究所 === 98 === Diabetic nephropathy (DN) is a complication of diabetes mellitus which may lead to end-stage renal disease. Throughout its early course, DN has no symptoms. The first laboratory abnormality is a positive sign by microalbuminuria test. However, at this stage, a kidney biopsy clearly shows DN. Therefore, this study is designed to establish a new method to identify the differential expression of proteins in the kidney of control and streptozotocin (STZ)-induced diabetic rats in order to discover specific indicators for early diagnosis of DN. The Spregue-Dawley rats were sacrificed at 1, 4, 12, 24 weeks after i.p. injection of sodium citrate buffer or STZ. A thiol-specific fluorogenic reagent, 4-[2-(dimethylamino)ethyl]-7-chloro-2,1,3-benzoxadiazole-4-sulfonamide (DAABD-Cl) was utilized for the derivatization of proteins and then the derivatives were quantified and collected by high performance lipid chromatography with fluorescence detection (FD-HPLC). The isolated derivatives will be further identified by liquid chromatography tandem mass spectrometry (LC-MS/MS) with the MASCOT database searching system. After 1 week of injection, the expressions of approximately 7 proteins significantly changed. Only one protein had significantly changed after 4 weeks of injection. However, after 12 weeks of treatment, the number of altered proteins rose to 9. In addition, the changes appeared before the increase of microalbumin in the urine. The results may serve to find new biomarkers to improve early detection and new drug development in diabetic-related nephropathy.
author2 李仁愛
author_facet 李仁愛
Pei-Yun Tsai
蔡佩芸
author Pei-Yun Tsai
蔡佩芸
spellingShingle Pei-Yun Tsai
蔡佩芸
Proteome analysis of diabetic-related proteins in rat kidney by fluorogenic derivatization–liquid chromatography–tandem mass spectrometry (FD-LC-MS/MS) method
author_sort Pei-Yun Tsai
title Proteome analysis of diabetic-related proteins in rat kidney by fluorogenic derivatization–liquid chromatography–tandem mass spectrometry (FD-LC-MS/MS) method
title_short Proteome analysis of diabetic-related proteins in rat kidney by fluorogenic derivatization–liquid chromatography–tandem mass spectrometry (FD-LC-MS/MS) method
title_full Proteome analysis of diabetic-related proteins in rat kidney by fluorogenic derivatization–liquid chromatography–tandem mass spectrometry (FD-LC-MS/MS) method
title_fullStr Proteome analysis of diabetic-related proteins in rat kidney by fluorogenic derivatization–liquid chromatography–tandem mass spectrometry (FD-LC-MS/MS) method
title_full_unstemmed Proteome analysis of diabetic-related proteins in rat kidney by fluorogenic derivatization–liquid chromatography–tandem mass spectrometry (FD-LC-MS/MS) method
title_sort proteome analysis of diabetic-related proteins in rat kidney by fluorogenic derivatization–liquid chromatography–tandem mass spectrometry (fd-lc-ms/ms) method
publishDate 2010
url http://ndltd.ncl.edu.tw/handle/74321667674778863473
work_keys_str_mv AT peiyuntsai proteomeanalysisofdiabeticrelatedproteinsinratkidneybyfluorogenicderivatizationliquidchromatographytandemmassspectrometryfdlcmsmsmethod
AT càipèiyún proteomeanalysisofdiabeticrelatedproteinsinratkidneybyfluorogenicderivatizationliquidchromatographytandemmassspectrometryfdlcmsmsmethod
AT peiyuntsai dàshǔshènzàngzhōngtángniàobìngxiāngguāndànbáizhīdànbáizhìtǐzhīyíngguānggāoxiàonéngyèxiāngcéngxīchuànliánzhìpǔfēnxī
AT càipèiyún dàshǔshènzàngzhōngtángniàobìngxiāngguāndànbáizhīdànbáizhìtǐzhīyíngguānggāoxiàonéngyèxiāngcéngxīchuànliánzhìpǔfēnxī
_version_ 1718230733197148160